Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

bamf health inc. - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f 18 injection or not to administer sodium fluoride f 18 injection, taking into account the importance of the drug to the mother. the body of scientific information related to radioactive decay, drug tissue distribution, and drug elimination shows that less than 0.01% of the radioactivity administered remains in the body after 24 hours (10 half-lives). to minimize the risks to a nursing infant, interrupt nursing for at least 24 hours. in reported clinical experience in approximately 100 children, weight based doses (2.1 mbq/kg) ranging from 19 mbq-148 mbq (0.5 mci-4 mci) were used. sodium fluoride f 18 was shown to localize to areas of bone turnover including rapidly growing epiphyses in developing long bones. children are more sensitive to radiation and may be at higher risk of cancer from sodium fluoride f 18 injection.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

amd medicom inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.0272 g in 1 ml - indications: topical anti-carie preparation directions: - following prophylaxis treatment, fill 1/3 of tray with gel - insert tray in the patient’s mouth - have patient bite down lightly for 60 seconds - remove tray and have patient expectorate excess. advise patient not to eat, drink or rinse for 30 minutes after application medicinal ingredients: fluoride ions 1.23% w/w (from 2.72% w/w sodium fluoride)

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

amd medicom inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.0272 g in 1 g - indications: topical anti-caries preparation directions: - following prophylaxis treatment, fill ¼ of tray with foam - to dispense, shake bottle vigorously then invert applicator 180° downward to the bottom of the tray - insert tray, have patient bite down lightly for a minimum of 60 seconds, up to 4 minutes - remove tray and have patient expectorate excess advise patient not to eat, drink or rinse for 30 minutes after the treatment medicinal ingredients: fluoride ions 1.23% w/w (from 2.72% w/w sodium fluoride)

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

patterson dental supply inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - sodium fluoride 123 mg in 1 g - for topical application to aid in the prevention of dental caries. treatment frequency should not exceed 4 treatments per year. do not use if patient has a known allergy to fluoride or any of the other ingredients in this product.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

patterson dental supply inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - sodium fluoride 123 mg in 1 g - for topical application to aid in the prevention of dental caries. treatment frequency should not exceed 4 treatments per year. do not use if patient has a known allergy to fluoride or any of the other ingredients in this product.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

amd medicom inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.0272 g in 1 ml - indications: a topical anti-caries preparation directions: - following prophylaxis treatment, fill 1/3 of tray with gel - insert tray in the patient’s mouth - have patient bite down lightly for 60 seconds - remove tray and have patient expectorate excess advise patient not to eat, drink or rinse for 30 minutes after application. medicinal ingredients: fluoride ions 1.23% w/w (from 2.72% w/w sodium fluoride)

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

amd medicom inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion .0272 g in 1 ml - amd medicom inc. denticare pro-gel 2.72% topical sodium fluoride gel 60 second application (1.23% fluoride ions) cherry 16.23 fl oz / 480ml ndc 64778-0214-1 npn 80008336 rx only us item code 10021-ch

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

sancilio & company inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg in 1 ml - as a supplemental source of fluoride. it has been established that ingestion of fluoridated drinking water (1 ppm f) during the period of tooth development results in significant decrease in the incidence of dental caries.1 sodium fluoride drops were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to age 3 and older, living in areas where the drinking water fluoride level does not exceed 0.6 ppm f. do not use in areas where drinking water exceeds 0.6 ppm f. do not administer to pediatric patients less than 6 months old.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

hto nevada inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg - for once daily, self-administered, systemic use as a dental caries preventive in pediatric patients.  it has been established that ingestion of fluoridated drinking water ( 1 ppm f ) during the period of tooth development results in a significant decrease in the incidence of dental caries.  kirkman's 1.1 mg sodium fluoride tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients form 6 months to 16 years of age living in areas where the drinking water fluoride content does not exceed 0.6 ppm (f). krikman's 1.1 mg sodium fluoride tablets, are contraindicated when the fluoride content of drinking water is 0.6 ppm (f) or more and should not be administered to pediatric patients under the age of 6 months.  do not administer fluoride (any strength) to pediatric patients under age 6 months. the use of kirkman's 1.1 mg sodium fluoride tablets as a caries preventive in pediatric age groups 6 months to 16 years is supported by evidence from adequate and well-controlled studies

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

decatur memorial hospital - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk.  because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium